In Vivo Activity Of Arry-380: A Potent, Small Molecule Inhibitor Of Erbb-2 In Combination With Trastuzumab Or Docetaxel In A Bt-474 Human Breast Carcinoma Xenograft Model.
CANCER RESEARCH（2009）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined